Pharmaceutical Patents Topic 80

Pharmaceutical Patents Topic 80 - Whitman College 1 WNDI...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Whitman College 1 WNDI 2009 File Title ***Topic Overview*** ...................................................................................................................... 2 .............................................................................................................................................................. 2 ***Definitions*** ............................................................................................................................... 3 ***AFF*** .......................................................................................................................................... 6 AFF CASE ........................................................................................................................................... 6 Evidence ............................................................................................................................................. 12 Harms ................................................................................................................................................. 12 Public Health First ........................................................................................................................... 18 SQUO Fails ....................................................................................................................................... 26 Answers To ........................................................................................................................................ 27 Case Studies ...................................................................................................................................... 35 ***NEG*** ....................................................................................................................................... 39 NEG CASE ........................................................................................................................................ 39 Innovation Key ................................................................................................................................. 43 Compulsory licensing discourages R&D ...................................................................................... 45 Generics Bad ..................................................................................................................................... 53 Trade key ........................................................................................................................................... 54 Answers To ........................................................................................................................................ 58 Benefits of Strong Patents ............................................................................................................... 61 New industries need patent protection to develop ....................................................................... 62 Compulsory Licensing Bad...
View Full Document

This note was uploaded on 02/23/2012 for the course DEBATE 101 taught by Professor None during the Spring '12 term at University of California, Berkeley.

Page1 / 68

Pharmaceutical Patents Topic 80 - Whitman College 1 WNDI...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online